Go to
JCI Insight
Citations to this article
M Mrug, … , J F Prchal, J T Prchal
Published November 1, 1997
Citation Information: J Clin Invest. 1997;100(9):2310-2314. https://doi.org/10.1172/JCI119769.
Citation Information: J Clin Invest. 1997;100(9):2310-2314. https://doi.org/10.1172/JCI119769.
Abstract
Research Article
Authors
M Mrug, T Stopka, B A Julian, J F Prchal, J T Prchal
Total citations by year
Citation information
Citations to this article (189)
| Title and authors | Publication | Year |
|---|---|---|
|
Renal damage-induced hepcidin accumulation contributes to anemia in angiotensinogen-deficient mice
Rodrigues AF, Boreggio L, Lahuta T, Qadri F, Alenina N, Barros CC, Todiras M, Bader M |
Clinical Science (London, England : 1979) | 2025 |
|
Association Between the Polymorphism of Angiotensin-Converting Enzyme Gene and Interleukin-1 Beta Gene and the Response to Erythropoietin Therapy in Dialysis Patients with Anemia
Dzekova-Vidimliski P, Eftimovska-Otovikj N, Nikolov IG, Selim G, Rambabova-Bushljetik I, Pushevski V, Karanfilovski V, Matevska-Geshovska N, Dimovski A |
2024 | |
|
The effect of the four pharmacological pillars of heart failure on haemoglobin level
Hullon D, Taherifard E, Al-Saraireh TH |
Annals of Medicine and Surgery | 2024 |
|
Angiotensin II promotes erythroid proliferation in a three-stage erythroid culture system
Poldee S, Metheetrairut C, Suthammarak W, Trakarnsanga K |
MethodsX | 2024 |
|
Retrospective Analysis of Factors Influencing the Hemoglobin Level-increasing Effect of Sodium-glucose Co-transporter-2 Inhibitors.
Yoshida Y, Yamada H, Sato J |
In vivo (Athens, Greece) | 2024 |
|
A systematic review and meta-analysis of factors contributing to post-kidney transplant anemia and the effect of erythropoietin-stimulating agents.
Chienwichai K, Phirom S, Wuttiputhanun T, Leelahavanichkul A, Townamchai N, Avihingsanon Y, Udomkarnjananun S |
Systematic reviews | 2024 |
|
How to diagnose iron deficiency in chronic disease: A review of current methods and potential marker for the outcome.
Rohr M, Brandenburg V, Brunner-La Rocca HP |
European Journal of Medical Research | 2023 |
|
Primary Arterial Hypertension and Drug-Induced Hypertension in Philadelphia-Negative Classical Myeloproliferative Neoplasms: A Systematic Review.
Găman MA, Kipkorir V, Srichawla BS, Dhali A, Găman AM, Diaconu CC |
Biomedicines | 2023 |
|
High intact fibroblast growth factor 23 levels associated with low hemoglobin levels in patients on chronic hemodialysis.
Fang YW, Wang JT, Lin TY, Lee CJ, Jang TN, Tsai MH, Liou HH |
Frontiers in Medicine | 2023 |
|
Treatment Options for Anemia in Kidney Transplant Patients: A Review.
Bonomini M, Di Liberato L, Sirolli V |
2023 | |
|
Cell-Free DNA: Potential Application in COVID-19 Diagnostics and Management
R Stawski, D Nowak, E Perdas |
Viruses | 2022 |
|
Angiotensin-converting enzyme inhibitors have adverse effects in anti-angiogenesis therapy for hepatocellular carcinoma
S Zhang, M Cao, Z Hou, X Gu, Y Chen, L Chen, Y Luo, L Chen, D Liu, H Zhou, K Zhu, Z Wang, X Zhang, X Zhu, Y Cui, H Li, H Guo, T Zhang |
Cancer Letters | 2021 |
|
Renin-angiotensin system is involved in embryonic emergence of hematopoietic stem/progenitor cells: RAS AND HEMATOPOIETIC EMERGENCE
E Julien, K Biasch, RE Omar, JN Freund, C Gachet, F Lanza, M Tavian |
Stem Cells | 2021 |
|
Discontinuation of the renin–angiotensin system inhibitors improves erythropoiesis in patients with lower-risk myelodysplastic syndromes
G Pavlidis, SG Papageorgiou, E Bazani, A Bouchla, E Glezou, K Gkontopoulos, T Thomopoulos, V Pappa, DV Vlahakos |
Therapeutic Advances in Hematology | 2021 |
|
JAK2 unmutated erythrocytosis: current diagnostic approach and therapeutic views
N Gangat, N Szuber, A Pardanani, A Tefferi |
Leukemia | 2021 |
|
Angiotensin II modulates the murine hematopoietic stem cell and progenitors cocultured with stromal S17 cells
MM Costa, RS Stilhano, CR Oliveira, CM Barbosa, GJ Pereira, EJ ParedesGamero, CR Nakaie, SS Smaili, C Bincoletto |
Cell Biology International | 2021 |
|
Post‐transplantation erythrocytosis in kidney transplant recipients—A retrospective cohort study
L Hofstetter, B RozenZvi, A Schechter, P Raanani, O Itzhaki, R Rahamimov, A GafterGvili |
European Journal of Haematology | 2021 |
|
The effect of myxomatous mitral valve disease severity on packed cell volume in dogs
J Wilshaw, M Stein, N Lotter, J Elliott, A Boswood |
Journal of Small Animal Practice | 2021 |
|
Cell-free DNA tissues of origin by methylation profiling reveals significant cell, tissue, and organ-specific injury related to COVID-19 severity
AP Cheng, MP Cheng, W Gu, JS Lenz, E Hsu, E Schurr, G Bourque, M Bourgey, J Ritz, FM Marty, CY Chiu, DC Vinh, ID Vlaminck |
The American Journal of Medicine | 2021 |
|
Haematological Indicators of Response to Erythropoietin Therapy in Chronic Renal Failure Patients on Haemodialysis: Impact of Angiotensin-Converting Enzyme rs4343 Gene Polymorphism
AH Almaeen, G Mostafa-Hedeab |
Pharmacogenomics and Personalized Medicine | 2021 |
|
Investigation of the effects of angiotensin converting enzyme inhibitors and angiotensin receptor blockers on anemia in patients with normal or mildly low glomerular filtration rate.
Ergün B, Aybal Kutlugün A, Ergün MÇ, Aktürk G, Beyan E |
2021 | |
|
Effect of angiotensin II and angiotensin‐(1–7) on proliferation of stem cells from human dental apical papilla
LM Macedo, RI Ávila, GR Pedrino, DB Colugnati, MC Valadares, EM Lima, CL Borges, GT Kitten, E Gava, CH Castro |
Journal of Cellular Physiology | 2020 |
|
Efficacy of telmisartan for the treatment of persistent renal proteinuria in dogs: A double‐masked, randomized clinical trial
BN Lourenço, AE Coleman, SA Brown, CW Schmiedt, MC Parkanzky, KE Creevy |
Journal of Veterinary Internal Medicine | 2020 |
|
A novel germline gain-of-function HIF2A mutation in hepatocellular carcinoma with polycythemia
J Yu, X Shi, C Yang, P Bullova, CS Hong, CL Nesvick, P Dmitriev, K Pacak, Z Zhuang, H Cao, L Li |
Aging | 2020 |
|
Duration of neonatal oxygen supplementation, erythropoiesis and blood pressure in young adults born preterm
A Flahault, C Girard-Bock, RO Fernandes, A Cloutier, YD Pastore, TM Luu, AM Nuyt |
Thorax | 2020 |
|
Cell-Free DNA in Blood Reveals Significant Cell, Tissue and Organ Specific injury and Predicts COVID-19 Severity.
Cheng AP, Cheng MP, Gu W, Lenz JS, Hsu E, Schurr E, Bourque G, Bourgey M, Ritz J, Marty F, Chiu CY, Vinh DC, Vlaminck I |
medRxiv : the preprint server for health sciences | 2020 |
|
The Role of Local Bone Marrow Renin-Angiotensin System in Multiple Myeloma
B Saka, M Sayitoğlu, Z İstemihan, MA Karan, N Erten, Ö Doğan, U Özbek, S Genç, C Taşcıoğlu, SK Beşışık |
Turkish Journal of Hematology | 2019 |
|
Interstitial fibroblasts in donor kidneys predict late posttransplant anemia
Mafune Hamada A, Yamamoto I, Kawabe M, Katsumata H, Yamakawa T, Katsuma A, Nakada Y, Kobayashi A, Koike Y, Miki J, Yamada H, Kimura T, Tanno Y, Ohkido I, Tsuboi N, Yamamoto H, Urashima M, Yokoo T |
Clinical Kidney Journal | 2019 |
|
Ethnic prevalence of anemia and predictors of anemia among chronic kidney disease patients at a tertiary hospital in Johannesburg, South Africa AM Nalado, J Mahlangu, B Waziri, R Duarte, G Paget, G Olorunfemi, S Naicker |
International journal of nephrology and renovascular disease | 2019 |
|
The Influence of Cardiovascular Medications on Iron Metabolism in Patients with Heart Failure
O Sirbu, V Sorodoc, IM Jaba, M Floria, A Stoica, L Profire, C Tuchilus, G Rusu, L Sorodoc |
MED LITH | 2019 |
|
Anemia and iron deficiency among chronic kidney disease Stages 3–5ND patients in the Chronic Kidney Disease Outcomes and Practice Patterns Study: often unmeasured, variably treated
MM Wong, C Tu, Y Li, RL Perlman, R Pecoits-Filho, AA Lopes, I Narita, H Reichel, FK Port, N Sukul, B Stengel, BM Robinson, ZA Massy, RL Pisoni, C Combe, C Jacquelinet, C Ayav, S Briançon, D Fouque, L Frimat, M Laville, C Lange, K Legrans, S Liabeuf, M Metzger, E Speyer |
Clinical Kidney Journal | 2019 |
|
Interstitial fibroblasts in donor kidneys predict late posttransplant anemia
AM Hamada, I Yamamoto, M Kawabe, H Katsumata, T Yamakawa, A Katsuma, Y Nakada, A Kobayashi, Y Koike, J Miki, H Yamada, T Kimura, Y Tanno, I Ohkido, N Tsuboi, H Yamamoto, M Urashima, T Yokoo |
Clinical Kidney Journal | 2019 |
|
Secretory factors from OP9 stromal cells delay differentiation and increase the expansion potential of adult erythroid cells in vitro
K Trakarnsanga, MC Wilson, KJ Heesom, TN Andrienko, C Srisawat, J Frayne |
Scientific Reports | 2018 |
|
Post-transplant erythrocytosis refractory to ACE inhibitors and angiotensin receptor blockers
P Vishnu, YM Vanegas, HM Wadei, CE Rivera |
BMJ case reports | 2018 |
|
The Renin-Angiotensin-Aldosterone System
SE Thatcher |
The Renin-Angiotensin-Aldosterone System | 2017 |
|
The impact of anaemia and iron deficiency in chronic obstructive pulmonary disease: A clinical overview
AR Nunes, M Tátá |
Revista Portuguesa de Pneumologia (English Edition) | 2017 |
|
Hyperbilirubinemia, Hypertension, and CKD: the Links
I Mortada |
Current Hypertension Reports | 2017 |
|
Renin-angiotensin system blockade promotes a cardio-renal protection in albuminuric homozygous sickle cell patients
JP Haymann, N Hammoudi, KS Stojanovic, F Galacteros, A Habibi, V Avellino, P Bartolucci, Y Benzerara, JB Arlet, M Djebbar, E Letavernier, G Grateau, N Tabibzadeh, A Girshovich, M Chaignon, R Girot, P Levy, F Lionnet |
British Journal of Haematology | 2017 |
|
Effects of Renin-Angiotensin-Aldosterone System Blockade in Patients with End-Stage Renal Disease
T Slomka, ES Lennon, H Akbar, EO Gosmanova, SK Bhattacharya, CS Oliphant, RN Khouzam |
The American Journal of the Medical Sciences | 2016 |
|
Clinical risk factors associated with the post-transplant anemia in kidney transplant patients
Y Chang, T Shah, DI Min, JW Yang |
Transplant Immunology | 2016 |
|
Renin–angiotensin–aldosterone system inhibitors lower hemoglobin and hematocrit only in renal transplant recipients with initially higher levels
I Mikolasevic, L Zaputovic, L Zibar, I Begic, M Zutelija, A Klanac, I Majurec, T Simundic, M Minazek, L Orlic |
European Journal of Internal Medicine | 2016 |
|
Anemia and markers of erythropoiesis in pediatric kidney transplant recipients compared to children with chronic renal failure
I Krause, M Davidovits, H Tamary, M Yutcis, A Dagan |
Pediatric Transplantation | 2016 |
|
ACE inhibitors and cytoreductive therapy in polycythemia vera
T Barbui, A Masciulli, A Ghirardi, A Carobbio |
Blood | 2016 |
|
Erythropoiesis and Blood Pressure Are Regulated via AT1 Receptor by Distinctive Pathways
H Kato, J Ishida, T Matsusaka, T Ishimaru, K Tanimoto, F Sugiyama, K Yagami, M Nangaku, A Fukamizu, M Bader |
PloS one | 2015 |
|
Mechanisms Linking Red Blood Cell Disorders and Cardiovascular Diseases
I Mozos |
BioMed Research International | 2015 |
|
NorLeu 3 -Angiotensin (1-7) [DSC127] as a Therapy for the Healing of Diabetic Foot Ulcers
KE Rodgers, LL Bolton, S Verco, GS diZerega |
Advances in Skin & Wound Care | 2015 |
|
The Decrement of Hemoglobin Concentration with Angiotensin II Receptor Blocker Treatment Is Correlated with the Reduction of Albuminuria in Non-Diabetic Hypertensive Patients: Post-Hoc Analysis of ESPECIAL Trial
JN An, JH Hwang, JP Lee, HJ Chin, S Kim, DK Kim, S Kim, JH Park, SJ Shin, SH Lee, BS Choi, CS Lim, G Reboldi |
PloS one | 2015 |
|
The Renin–Angiotensin System and Bone
J Tamargo, R Caballero, E Delpón |
Clinical Reviews in Bone and Mineral Metabolism | 2015 |
|
Role of angiotensin II in stem cell therapy of cardiac disease
E Ahmadian, S Jafari, AY Khosroushahi |
Journal of Renin-Angiotensin-Aldosterone System | 2015 |
|
Pediatric Nephrology
ED Avner, WE Harmon, P Niaudet, N Yoshikawa, F Emma, S Goldstein |
Pediatric Nephrology | 2015 |
|
The sex difference in haemoglobin levels in adults — Mechanisms, causes, and consequences
WG Murphy |
Blood Reviews | 2014 |
|
Clinical Implication of the Renin-angiotensin-aldosterone Blockers in Chronic Kidney Disease Undergoing Hemodialysis
Y Morishita, E Kusano, D Nagata |
The open cardiovascular medicine journal | 2014 |
|
Bilirubin and Progression of Nephropathy in Type 2 Diabetes: A Post Hoc Analysis of RENAAL With Independent Replication in IDNT
IJ Riphagen, PE Deetman, SJ Bakker, G Navis, ME Cooper, JB Lewis, D Zeeuw, HJ Heerspink |
Diabetes | 2014 |
|
Myeloproliferative Disorders
B Meier, JH Burton |
Emergency Medicine Clinics of North America | 2014 |
|
Effect of angiotensin-converting enzyme gene insertion/deletion polymorphism and angiotensin-converting enzyme inhibition on erythropoiesis in patients on haemodialysis
Z Kiss, C Ambrus, I Kulcsár, J Szegedi, I Kiss, A Benke, B Borbás, S Ferenczi, M Hengsperger, S Kazup, L Nagy, J Németh, A Rozinka, T Szabó, T Szelestei, E Tóth, G Varga, G Wágner, G Zakar |
Journal of Renin-Angiotensin-Aldosterone System | 2014 |
|
Contribution of the Local RAS to Hematopoietic Function: A Novel Therapeutic Target
KE Rodgers, GS Dizerega |
Frontiers in Endocrinology | 2013 |
|
Enhanced hematopoietic protection from radiation by the combination of genistein and captopril
RM Day, TA Davis, M Barshishat-Kupper, EA McCart, AJ Tipton, MR Landauer |
International Immunopharmacology | 2013 |
|
Anaemia in chronic obstructive pulmonary disease. Does it really matter?
K Portillo, C Martinez-Rivera, J Ruiz-Manzano |
International Journal of Clinical Practice | 2013 |
|
Effect of angiotensin converting enzyme inhibitors and angiotensin receptor blockers on hemoglobin levels
A Ajmal, CE Gessert, BP Johnson, CM Renier, JA Palcher |
BMC Research Notes | 2013 |
|
Prevalence and management of post-transplant anemia in long-term follow-up of Chinese kidney transplant recipients: a single-center report
Z Wu, J Guo, L Liao, W Wu, S Yang, J Tan |
European Journal of Medical Research | 2013 |
|
Angiotensin-(1–7) synergizes with colony-stimulating factors in hematopoietic recovery
KE Rodgers, TB Espinoza, N Roda, CJ Meeks, GS diZerega |
Cancer Chemotherapy and Pharmacology | 2013 |
|
A Modern Understanding of the Traditional and Nontraditional Biological Functions of Angiotensin-Converting Enzyme
KE Bernstein, FS Ong, WL Blackwell, KH Shah, JF Giani, RA Gonzalez-Villalobos, XZ Shen, S Fuchs, RM Touyz |
Pharmacological reviews | 2012 |
|
Anemia in Heart Failure Patients
MG Alexandrakis, G Tsirakis |
ISRN Hematology | 2012 |
|
Anemia and Iron Deficiency in Heart Failure
S Gunawardena, ME Dunlap |
Current Heart Failure Reports | 2012 |
|
Angiotensin-converting enzyme (CD143) specifies emerging lympho-hematopoietic progenitors in the human embryo
L Sinka, K Biasch, I Khazaal, B Peault, M Tavian |
Blood | 2012 |
|
Brenner and Rector's The Kidney
C Brugnara, KU Eckardt |
Brenner and Rector's The Kidney | 2012 |
|
The renin–angiotensin system, bone marrow and progenitor cells
M Durik, B Sevá Pessôa, AJ Roks |
Clinical Science | 2012 |
|
Local bone marrow renin–angiotensin system in primitive, definitive and neoplastic haematopoiesis
IC Haznedaroglu, Y Beyazit |
Clinical Science | 2012 |
|
Occurrence and determinants of poor response to short-term pre-operative erythropoietin treatment: Poor response to pre-operative erythropoietin
IM van Haelst, AC Egberts, HJ Doodeman, WW van Solinge, CJ Kalkman, M Bennis, HS Traast, WA van Klei |
Acta Anaesthesiologica Scandinavica | 2012 |
|
Current Perspectives on Protective Roles of Erythropoietin in Cardiovascular System: Erythropoietin Receptor as a Novel Therapeutic Target
Y Kagaya, Y Asaumi, W Wang, M Takeda, M Nakano, K Satoh, Y Fukumoto, H Shimokawa |
The Tohoku Journal of Experimental Medicine | 2012 |
|
Introduction of angiotensin-converting enzyme inhibitors induces a fall in hemoglobin levels in elderly patients hospitalized with heart failure: a cohort study
A Laudisio, E Marzetti, F Pagano, R Bernabei |
Aging clinical and experimental research | 2012 |
|
Inhibition of the Renin Angiotensin System during Autologous Stem Cell Transplant Does Not Impact Time to Engraftment
AJ Kumar, J Carver, NV Frey |
Open Journal of Blood Diseases | 2012 |
|
Accelerated hematopoietic recovery with angiotensin-(1–7) after total body radiation
KE Rodgers, T Espinoza, N Roda, CJ Meeks, C Hill, SG Louie, GS Dizerega |
International Journal of Radiation Biology | 2012 |
|
Angiotensin-converting enzyme is required for normal myelopoiesis
C Lin, V Datta, D Okwan-Duodu, X Chen, S Fuchs, R Alsabeh, S Billet, KE Bernstein, XZ Shen |
The FASEB Journal | 2011 |
|
Clinical impact of hypercalcemia in kidney transplant
P Messa, C Cafforio, C Alfieri |
International Journal of Nephrology | 2011 |
|
Autosomal Dominant Mutations in the Signal Peptide of Renin in a Kindred With Anemia, Hyperuricemia, and CKD
BB Beck, H Trachtman, M Gitman, I Miller, JA Sayer, A Pannes, A Baasner, F Hildebrandt, MT Wolf |
American Journal of Kidney Diseases | 2011 |
|
Effects of the renin angiotensin system on vasculogenesis-related progenitor cells
AJ Roks, K Rodgers, T Walther |
Current Opinion in Pharmacology | 2011 |
|
Captopril modulates hypoxia-inducible factors and erythropoietin responses in a murine model of total body irradiation
M Barshishat-Kupper, O Mungunsukh, AJ Tipton, EA McCart, RA Panganiban, TA Davis, MR Landauer, RM Day |
Experimental Hematology | 2011 |
|
Angiotensin II-dependent hypertension causes reversible changes in the platelet proteome :
S Gebhard, L Steil, B Peters, M Gesell-Salazar, E Hammer, B Kuttler, KJ Clemetson, C Scharf, J Peters, U Völker, R Rettig, A Greinacher |
Journal of Hypertension | 2011 |
|
Accelerated healing of diabetic wounds by NorLeu(3)-angiotensin (1-7)
K Rodgers, S Verco, L Bolton, G Dizerega |
Expert Opinion on Investigational Drugs | 2011 |
|
Effects of the NUP98-DDX10 oncogene on primary human CD34+ cells: role of a conserved helicase motif
ER Yassin, AM Abdul-Nabi, A Takeda, NR Yaseen |
Leukemia | 2010 |
|
Alternatives to Blood Transfusion in Transfusion Medicine
PL Baele |
Alternatives to Blood Transfusion in Transfusion Medicine | 2010 |
|
Crucial role of renin-angiotensin system in the pathogenesis of atherosclerosis
M Sata, D Fukuda |
The Journal of Medical Investigation | 2010 |
|
The Role of the Renin-Angiotensin System in the Regulation of Erythropoiesis
DV Vlahakos, KP Marathias, NE Madias |
American Journal of Kidney Diseases | 2010 |
|
Management of Anemia and Iron Deficiency in Heart Failure
E O’Meara, S Denus |
Current Treatment Options in Cardiovascular Medicine | 2010 |
|
Erythropoietin is reduced by combination of diuretic therapy and RAAS blockade in proteinuric renal patients with preserved renal function
MC Slagman, SJ Sinkeler, MH Hemmelder, F Waanders, L Vogt, HC Kluin-Nelemans, G Navis, GD Laverman |
Nephrology Dialysis Transplantation | 2010 |
|
Anaemia and heart failure
E Vizzardi, T Bordonali, E Tanghetti, M Metra, LD Cas |
Central European Journal of Medicine | 2010 |
|
Myelopoiesis modulation by ACE hyperfunction in kinin B1 receptor knockout mice: Relationship with AcSDKP levels
CR Oliveira, EJ Paredes-Gamero, CM Barbosa, FD Nascimento, EC Batista, FC Reis, AH Martins, AT Ferreira, AK Carmona, JB Pesquero, IL Tersariol, RC Araújo, C Bincoletto |
Chemico-Biological Interactions | 2010 |
|
Pathophysiology of Anemia in Heart Failure
IS Anand |
Heart Failure Clinics | 2010 |
|
Clinical and molecular characterization of a family with a dominant renin gene mutation and response to treatment with fludrocortisone
A.J. Bleyer, M. Živná, H. Hulková, K. Hodanová, P. Vyletal, J. Sikora, J. Živný, J. Sovová, T.C. Hart, J.N. Adams, M. Elleder, K. Kapp, R. Haws, L.D. Cornell, S. Kmoch, P.S. Hart |
Clinical nephrology | 2010 |
|
Management of anemia and iron deficiency in heart failure.
O'Meara E, de Denus S |
Current Treatment Options in Cardiovascular Medicine | 2010 |
|
A role for the renin-angiotensin system in hematopoiesis
TS Park, ET Zambidis |
Haematologica | 2009 |
|
Serum Stem Cell Factor Level in Renal Transplant Recipients With Posttransplant Erythrocytosis
AA Kiykim, G Genctoy, M Horoz, NE Tiftik, E Gok, B Altun, M Arici, I Haznedaroglu |
Artificial Organs | 2009 |
|
Anemia and heart failure
JK Ghali |
Current Opinion in Cardiology | 2009 |
|
Anemia in Chronic Heart Failure
SG Drakos, MI Anastasiou-Nana, KG Malliaras, JN Nanas |
Congestive Heart Failure | 2009 |
|
Induction of apoptosis in leukemic cell lines treated with captopril, trandolapril and losartan: A new role in the treatment of leukaemia for these agents
SD la Iñigo, CE López-Jorge, MT Gómez-Casares, AL Castellano, PM Cabrera, JL Brito, AS Cabrera, TM Labarta |
Leukemia Research | 2009 |
|
Expression of angiotensin-converting enzyme (CD143) identifies and regulates primitive hemangioblasts derived from human pluripotent stem cells
ET Zambidis, TS Park, W Yu, A Tam, M Levine, X Yuan, M Pryzhkova, B Péault |
Blood | 2008 |
|
Polymorphisms in two genes, IL-1B and ACE, are associated with erythropoietin resistance in Korean patients on maintenance hemodialysis
KH Jeong, TW Lee, CG Ihm, SH Lee, JY Moon |
Experimental & molecular medicine | 2008 |
|
Heart failure and anemia: mechanisms and pathophysiology
IS Anand |
Heart Failure Reviews | 2008 |
|
Therapy in Nephrology & Hypertension
WL Whittier, JB Lewis, EJ Lewis |
Therapy in Nephrology & Hypertension | 2008 |
|
Role of bone marrow renin–angiotensin system in the pathogenesis of atherosclerosis
D Fukuda, M Sata |
Pharmacology & Therapeutics | 2008 |
|
Mechanisms of Disease: erythropoietin resistance in patients with both heart and kidney failure
K der Putten, B Braam, KE Jie, CA Gaillard |
Nature Clinical Practice Nephrology | 2008 |
|
Angiotensin-converting enzyme (CD143) marks hematopoietic stem cells in human embryonic, fetal, and adult hematopoietic tissues
VJ Jokubaitis, L Sinka, R Driessen, G Whitty, DN Haylock, I Bertoncello, I Smith, B Peault, M Tavian, PJ Simmons |
Blood | 2008 |
|
Association between Erythropoietin Requirements and Antihypertensive Agents
S Yano, K Suzuki, M Iwamoto, Y Urushidani, H Yokogi, M Kusakari, A Aoki, M Sumi, K Kitamura, H Sanematsu, M Gohbara, S Imamura, T Sugimoto |
Nephron Clinical Practice | 2008 |
|
Effects of the Renin–Angiotensin System Blockade on Hemoglobin Levels in Type 2 Diabetic Patients With Chronic Kidney Disease
A Inoue, T Babazono, Y Iwamoto |
American Journal of Hypertension | 2008 |
|
Prevalence and characteristics of anaemia in diabetes
OR Adetunji, H Mani, A Olujohungbe, J Ronald, C Morgan, G Gill |
Practical Diabetes International | 2008 |
|
Anemia and Chronic Heart Failure
IS Anand |
Journal of the American College of Cardiology | 2008 |
|
Angiotensin-Converting Enzyme Gene Polymorphism Is Associated with Anemia in Non–Small-Cell Lung Cancer
A Yaren, I Oztop, S Turgut, G Turgut, S Degirmencioglu, M Demirpence |
Experimental biology and medicine (Maywood, N.J.) | 2008 |
|
Interventional Treatment of Advanced Ischemic Heart Disease
R Delgado |
2008 | |
|
Anemia and heart failure: a cause of progression or only a consequence?
M Metra, S Nodari, T Bordonali, S Bugatti, B Fontanella, C Lombardi, A Saporetti, G Verzura, R Danesi, LD Cas |
Heart International | 2007 |
|
Polycythemia and increased erythropoietin in a patient with chronic kidney disease
S Stark, B Winkelmann, C Kluthe, J Roigas, U Querfeld, D Müller |
Nature Clinical Practice Nephrology | 2007 |
|
Treatment of Erythrocytosis Associated with Obesity Hypoventilation Syndrome
L Mascitelli, F Pezzetta |
The American Journal of Medicine | 2007 |
|
The Reply
AL Olson, C Zwillich |
The American Journal of Medicine | 2007 |
|
The effect of losartan on hemoglobin concentration and renal outcome in diabetic nephropathy of type 2 diabetes
A Mohanram, Z Zhang, S Shahinfar, PA Lyle, RD Toto |
Kidney International | 2007 |
|
Treatment of chronic mountain sickness: Critical reappraisal of an old problem
M Rivera-Ch, F León-Velarde, L Huicho |
Respiratory Physiology & Neurobiology | 2007 |
|
Myeloproliferative Disorders: Biology and Management
P Valent, C Akin, HP Horny, D Metcalfe |
Myeloproliferative Disorders: Biology and Management | 2007 |
|
Anemia and Heart Failure: A Cause of Progression or Only a Consequence?
M Metra, S Nodari, T Bordonali, S Bugatti, B Fontanella, C Lombardi, A Saporetti, G Verzura, R Danesi, LD Cas |
Heart International | 2007 |
|
Erythropoietin Dose and Angiotensin-Converting Enzyme Inhibitors
AE Grzegorzewska |
Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis | 2007 |
|
ACE Gene Polymorphism and Erythropoietin in Endurance Athletes at Moderate Altitude
AJ Gonz??Lez, D Hern??Ndez, AD Vera, Y Barrios, E Salido, A Torres, NS Terrados |
Medicine & Science in Sports & Exercise | 2006 |
|
The hematopoietic system: a new niche for the renin–angiotensin system
C Hubert, K Savary, JM Gasc, P Corvol |
Nature Clinical Practice Cardiovascular Medicine | 2006 |
|
Relevance of renin expression by real-time PCR in acute myeloid leukemia
SI la Iñigo, MT Casares, CE Jorge, SM Leiza, GS Santana, SJ de Laguna, JD san Miguel, A Caballero, MD Álvarez, AL Castellano, HL Henríquez, TM Labarta |
Leukemia & Lymphoma | 2006 |
|
A Role for Angiotensin-Converting Enzyme in the Characterization, Enrichment, and Proliferation Potential of Adult Murine Pituitary Colony-Forming Cells
DA Lepore, VJ Jokubaitis, PJ Simmons, KN Roeszler, R Rossi, K Bauer, PQ Thomas |
Stem Cells | 2006 |
|
Genetics in Dialysis: Gene Polymorphism Association Studies in Dialysis: Anemia and Host Immunity
BL Jaber, VS Balakrishnan, M Girndt, GH Heine, H Köhler |
Seminars in Dialysis | 2006 |
|
Erythropoietins and Erythropoiesis
G Molineux, MA Foote, SG Elliott |
2006 | |
|
The Local Cardiac Renin Angiotensin-Aldosterone System
ED Frohlich, RN Re |
2006 | |
|
Erythropoietin Dose: Determined by the Genes?
EA Brown |
Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis | 2006 |
|
The Effect of Proinflammatory Cytokine Gene and Angiotensin-Converting Enzyme Polymorphisms on Erythropoietin Requirements in Patients on Continuous Ambulatory Peritoneal Dialysis
EJ Sharples, M Varagunam, PJ Sinnott, DJ McCloskey, MJ Raftery, MM Yaqoob |
Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis | 2006 |
|
Phase I/II dose escalation study of angiotensin 1-7 [A(1-7)] administered before and after chemotherapy in patients with newly diagnosed breast cancer
KE Rodgers, J Oliver, GS diZerega |
Cancer Chemotherapy and Pharmacology | 2005 |
|
Effect of angiotensin II on cord blood CD34+ cells expansionin vitro
P Cheng, Z Ping, M Yanping, H Zongbo |
Journal of Huazhong University of Science and Technology [Medical Sciences] | 2005 |
|
Anemia in heart failure-A concise review
S Vasu, P Kelly, WE Lawson |
Clinical Cardiology | 2005 |
|
Anemia and COPD
L Mascitelli, F Pezzetta |
Chest | 2005 |
|
Role of the renin-angiotensin system in primitive erythropoiesis in the chick embryo
K Savary, A Michaud, J Favier, E Larger, P Corvol, JM Gasc |
Blood | 2005 |
|
Anemia in Chronic Kidney Disease Patients
A Rastogi, AR Nissenson |
Transfusion Alternatives in Transfusion Medicine | 2005 |
|
Angiotensin-converting enzyme inhibitor as a risk factor for the development of anemia, and the impact of incident anemia on mortality in patients with left ventricular dysfunction
A Ishani, E Weinhandl, Z Zhao, DT Gilbertson, AJ Collins, S Yusuf, CA Herzog |
Journal of the American College of Cardiology | 2005 |
|
Anemia Due to Losartan in Hypertensive Renal Transplant Recipients Without Posttransplant Erythrocytosis
A Ersoy, S Kahvecioglu, C Ersoy, A Cift, K Dilek |
Transplantation Proceedings | 2005 |
|
Enhanced erythropoiesis mediated by activation of the renin‐angiotensin system via angiotensin II type 1a receptor
H Kato, J Ishida, S Imagawa, T Saito, N Suzuki, T Matsuoka, T Sugaya, K Tanimoto, T Yokoo, O Olmeda, F Sugiyama, KI Yagami, T Fujita, M Yamamoto, M Nangaku, A Fukamizu |
The FASEB Journal | 2005 |
|
Angiotensin II stimulates arachidonic acid release from bone marrow stromal cells
RS Richmond, EA Tallant, PE Gallagher, CM Ferrario, WB Strawn |
Journal of Renin-Angiotensin-Aldosterone System | 2004 |
|
Angiotensin II receptor type 1 expression in erythroid progenitors: implications for the pathogenesis of postrenal transplant erythrocytosis
M Mrug, BA Julian, JT Prchal |
Seminars in Nephrology | 2004 |
|
Renin-angiotensin system expression in rat bone marrow haematopoietic and stromal cells
WB Strawn, RS Richmond, EA Tallant, PE Gallagher, CM Ferrario |
British Journal of Haematology | 2004 |
|
Comparative Effects of Fosinopril and Irbesartan on Hematopoiesis in Essential Hypertensives
NR Robles, E Angulo, J Grois, A Barquero |
Renal Failure | 2004 |
|
How hematopoietic stem cells know and act in cardiac microenvironment for stem cell plasticity? Impact of local renin–angiotensin systems
MA Öztürk, GS Güven, IC Haznedaroglu |
Medical Hypotheses | 2004 |
|
Polycythemia and oxygen sensing
J Maran, J Prchal |
Pathologie Biologie | 2004 |
|
Apoptotic mechanisms in the control of erythropoiesis
U Testa |
Leukemia | 2004 |
|
Ontogenèse du système rénine. Implication de ce système dans l'hématopoïèse
P Corvol |
Bulletin de l'Académie nationale de médecine | 2004 |
|
Inhibition of angiotensin I–converting enzyme induces radioprotection by preserving murine hematopoietic short-term reconstituting cells
S Charrier, A Michaud, S Badaoui, S Giroux, E Ezan, F Sainteny, P Corvol, W Vainchenker |
Blood | 2004 |
|
Perturbation of autocrine/paracrine loops of burst-forming units of erythroid-derived cells in rHuEPO-hyporesponsive hemodialysis patients
K Nakao, J Wada, K Ota, H Ichikawa, S Akagi, A Okamoto, K Hida, Y Nagake, H Makino |
American journal of kidney diseases : the official journal of the National Kidney Foundation | 2003 |
|
Do alterations of endogenous angiotensin II levels regulate erythropoietin production in humans?
S Freudenthaler, P Benöhr, A Grenz, T Selzer, T Schmidt, K Mörike, H Osswald, CH Gleiter |
British Journal of Clinical Pharmacology | 2003 |
|
Posttransplant erythrocytosis
DV Vlahakos, KP Marathias, B Agroyannis, NE Madias |
Kidney International | 2003 |
|
Towards the understanding of the local hematopoietic bone marrow renin-angiotensin system
IC Haznedaroglu, MA Öztürk |
The International Journal of Biochemistry & Cell Biology | 2003 |
|
Angiotensin Receptor Blockers and Epoetin Resistance
EF Foote, D Germick |
Seminars in Dialysis | 2003 |
|
Angiotensin I-converting enzyme is expressed by erythropoietic cells of normal and myeloproliferative bone marrow
M Marusic-Vrsalovic, M Dominis, B Jaksic, R Kusec |
British Journal of Haematology | 2003 |
|
Post Transplant Erythrocytosis in Hypercalcemic Renal Transplant Recipients
M Kurella, DW Butterly, SR Smith |
American Journal of Transplantation | 2003 |
|
Polycythemia Vera: A Comprehensive Review and Clinical Recommendations
A Tefferi |
Mayo Clinic Proceedings | 2003 |
|
Angiotensin-Converting Enzyme Gene Polymorphism and Erythropoietin Requirement
M Varagunam, DJ McCloskey, PJ Sinnott, MJ Raftery, MM Yaqoob |
Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis | 2003 |
|
Angiotensin-converting-enzyme inhibition therapy in altitude polycythaemia: a prospective randomised trial
R Plata, A Cornejo, C Arratia, A Anabaya, A Perna, BD Dimitrov, G Remuzzi |
The Lancet | 2002 |
|
Routine renin-angiotensin system blockade in renal transplantation?
G Remuzzi, N Perico |
Current Opinion in Nephrology and Hypertension | 2002 |
|
New insights into erythropoiesis
MJ Koury, ST Sawyer, SJ Brandt |
Current Opinion in Hematology | 2002 |
|
Angiotensin II That Reduces the Colony-Forming Ability of Hematopoietic Progenitors in Serum Free Medium Has an Inverse Effect in Serum-Supplemented Medium
PB de la Grange, Z Ivanovic, V Leprivey-Lorgeot, V Praloran |
Stem Cells | 2002 |
|
Effects of losartan or enalapril on hemoglobin, circulating erythropoietin, and insulin-like growth factor-1 in patients with and without posttransplant erythrocytosis
AY Wang, AW Yu, CW Lam, LM Yu, PK Li, J Goh, SF Lui |
American Journal of Kidney Diseases | 2002 |
|
The spectrum of long-term renal transplantation: Outcomes, complications, and clinical studies
WE Braun, NG Yadlapalli |
Transplantation Reviews | 2002 |
|
Old antihypertensives as novel antineoplastics: angiotensin-I-converting enzyme inhibitors and angiotensin II type 1 receptor antagonists
H Abali, IH Güllü, H Engin, IC Haznedaroğlu, M Erman, G Tekuzman |
Medical Hypotheses | 2002 |
|
Postrenal transplant erythrocytosis: risk factors and effectiveness of angiotensin receptor antagonists
V Singh, K Sud, BR Mittal, HS Kohli, KL Gupta, V Sakhuja |
Transplantation Proceedings | 2002 |
|
ACEi-induced attenuation of platelet TIMP-1 production in renal allograft recipients. possible impact on erythropoiesis
BO Lightfoot, LL Mulloy, M Jagadeesan, S Ahmed, S Balachandran |
Transplantation Proceedings | 2002 |
|
Circulating and Local Bone Marrow Renin-angiotensin System in Leukemic Hematopoiesis: Preliminary Evidences
H Abali, IC Haznedarogˇlu, H Goker, I Çelik, D Özatlı, Z Koray, M Çagˇlar |
Hematology | 2002 |
|
Improving Prognosis for Kidney Disorders
MM Avram |
2002 | |
|
Effects of angiotensin-converting enzyme inhibitors on the treatment of anemia with erythropoietin
K Hayashi, K Hasegawa, S Kobayashi |
Kidney International | 2001 |
|
Angiotensin II infusion increases plasma erythropoietin levels via an angiotensin II type 1 receptor-dependent pathway
J Gossmann, R Burkhardt, S Harder, T Lenz, A Sedlmeyer, U Klinkhardt, H Geiger, EH Scheuermann |
Kidney International | 2001 |
|
Angiotensin-converting enzyme inhibitors reduce hemoglobin concentrations, hematocrit, and serum erythropoietin levels in renal transplant recipients without posttransplant erythrocytosis
D Montanaro, M Gropuzzo, P Tulissi, G Boscutti, A Risaliti, U Baccarani, G Mioni |
Transplantation Proceedings | 2001 |
|
ACE inhibitors and erythropoietin responsiveness
IC Macdougall |
American Journal of Kidney Diseases | 2001 |
|
Angiotensin-Converting Enzyme Inhibition Induces Apoptosis in Erythroid Precursors and Affects Insulin-Like Growth Factor-1 in Posttransplantation Erythrocytosis
D Glicklich, L Burris, A Urban, VI Tellis, S Greenstein, R Schechner, P Devarajan, H Croizat |
Journal of the American Society of Nephrology : JASN | 2001 |
|
Mice deficient in angiotensin converting enzyme (ACE) have anemia due to a lack of angiotensin II facilitated erythropoiesis
Justin Cole, Dilek Ertoy, Hsinchen Lin, Roy L. Sutliff, Eric Ezan, Tham T. Guyene, Mario Capecchi, Pierre Corvol, Kenneth E. Bernstein |
Journal of Clinical Investigation | 2000 |
|
Effect of Angiotensin II on Hematopoietic Progenitor Cell Proliferation
KE Rodgers, S Xiong, R Steer, GS diZerega |
Stem Cells | 2000 |
|
A unifying hypothesis for the renin–angiotensin system and hematopoiesis: sticking the pieces together with the JAK-STAT pathway
IC ǧ, M Arici, Y Büyükaşik |
Medical Hypotheses | 2000 |
|
Novel mechanisms linking angiotensin II and early atherogenesis
WB Strawn, RH Dean, CM Ferrario |
Journal of Renin-Angiotensin-Aldosterone System | 2000 |
|
EXPRESSION OF ANGIOTENSIN II TYPE I RECEPTOR ON ERYTHROID PROGENITORS OF PATIENTS WITH POST TRANSPLANT ERYTHROCYTOSIS1:
M Gupta, BA Miller, N Ahsan, PJ Ulsh, MY Zhang, JY Cheung, HC Yang |
Transplantation | 2000 |
|
The Hypertrophied Heart
N Takeda, M Nagano, NS Dhalla |
2000 | |
|
Purification, amplification and characterization of a population of human erythroid progenitors
Freyssinier, Lecoq-Lafon, Amsellem, Picard, Ducrocq, Mayeux, Lacombe, Fichelson |
British Journal of Haematology | 1999 |
|
Angiotensin II and connective tissue: homeostasis and reciprocal regulation
KT Weber |
Regulatory Peptides | 1999 |
|
The role of ACE inhibitors and angiotensin II receptor blockers in the response to epoetin
IC Macdougall |
Nephrology Dialysis Transplantation | 1999 |
|
Studies of erythroid burst-forming units in patients with posttransplant erythrocytosis
D Glicklich, T Kapoian, H Mian, S Greenstein, V Tellis, H Croizat |
Transplantation Proceedings | 1999 |
|
Treatment with losartan in kidney transplant recipients with posttransplant erythrocytosis
P Iñigo, JV Torregrosa, JM Campistol, F Oppenheimer |
Transplantation Proceedings | 1999 |
|
EFFECTS OF ERYTHROPOIETIN, ANGIOTENSIN II, AND ANGIOTENSIN-CONVERTING ENZYME INHIBITOR ON ERYTHROID PRECURSORS IN PATIENTS WITH POSTTRANSPLANTATION ERYTHROCYTOSIS:
D Glicklich, T Kapoian, H Mian, J Gilman, V Tellis, H Croizat |
Transplantation | 1999 |
|
The impact of withdrawing ACE inhibitors on erythropoietin responsiveness and left ventricular hypertrophy in haemodialysis patients
Ş Ertürk, G Nergizoğlu, K Ateş, N Duman, B Erbay, O Karatan, AE Ertuğ |
Nephrology Dialysis Transplantation | 1999 |
|
Angiotensin-II, Renal Anemia and Hyporesponsiveness to Recombinant Human Erythropoietin
H Schiffl, A Bergner |
The International Journal of Artificial Organs | 1999 |
|
Clinical Applications of Cytokines and Growth Factors
JR Wingard, GD Demetri |
1999 | |
|
Long-term follow-up of renal transplant recipients treated with losartan for post-transplant erythrosis
D Ducloux, V Fournier, C Bresson-Vautrin, JM Chalopin |
Transplant International | 1998 |
|
Is Plasma Ac-SDKP Level a Reliable Marker of Chronic Angiotensin-Converting Enzyme Inhibition in Hypertensive Patients?
YL Meur, JC Aldigier, V Praloran |
Hypertension | 1998 |
|
Human Hematopoietic Progenitors Express Erythropoietin
T Stopka, JH Zivny, P Stopkova, JF Prchal, JT Prchal |
Blood | 1998 |
|
Elevated level of erythropoietin in congestive heart failure relationship to renal perfusion and plasma renin
DV Vlahakos, EN Kosmas, I Dimopoulou, E Ikonomou, G Jullien, P Vassilakos, KP Marathias |
Journal of Internal Medicine | 1993 |
Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)